Zika virus diseaseNews & Research
3 curated articles for Zika virus disease — FDA updates, peer-reviewed research, clinical-trial milestones, and sponsor press releases. Sorted newest-first.
- Science progress May 11, 2026
Mathematical analysis and simulation of an ABC fractional Zika virus model with natural transform and stability assessment.
This work introduces an Atangana-Baleanu Caputo (ABC) fractional model for the transmission dynamics of the Zika virus. A novel Natural Transform approach is employed to obtain an approximate analytical solution and to examine the stability and uniqueness of the system. The positivity and boundednes...
Why it matters: Recent peer-reviewed research on Zika virus disease that may be relevant for patients and caregivers.
- Frontiers in microbiology May 8, 2026
Integrated transcriptome-microbiome analysis reveals a host-microbe interplay associated with insecticide resistance in Aedes albopictus .
Aedes albopictus is the primary vector of major arboviral diseases such as dengue fever, chikungunya fever, and Zika virus disease, and its control is highly dependent on chemical insecticides. However, the long-term use of pyrethroid insecticides has led to the development of insecticide resistance...
Why it matters: Recent peer-reviewed research on Zika virus disease that may be relevant for patients and caregivers.
- Parasites & vectors Mar 27, 2026
Differences in metaviromes between Aedes aegypti and Aedes albopictus from sympatric areas on Hainan Island and the Leizhou Peninsula, China.
Aedes aegypti and Ae. albopictus are the most important vector mosquito species globally and are capable of transmitting various viral diseases, such as dengue fever, zika virus disease, and chikungunya fever. Although they overlap in terms of ecological niches and geographical distribution, their v...
Why it matters: Recent peer-reviewed research on Zika virus disease that may be relevant for patients and caregivers.
More on Zika virus disease
Articles aggregated from peer-reviewed journals (PubMed), sponsor press releases, SEC 8-K filings, and FDA announcements. Original-source links are preserved on each article page. Editorial tags (Breaking / Notable / Update) reflect UniteRare's curation-time priority assessment.